Chronotype of Patients With Diabetes and Effect on Glycaemic Control

Summary

The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.

Eligibility

Inclusion Criteria:

1. Participant is willing and able to give informed consent for participation in the study
2. T1DM or established T2DM (\>6months since diagnosis)
3. Male or Female
4. Aged 18-75 years inclusive
5. BMI less than or equal to 45kg/m² inclusive
6. No known sleep disorders except Obstructive Sleep Apnoea (OSA)
7. On any glucose-lowering therapy (T1DM or T2DM) or lifestyle modification for management of T2DM
8. Good command of the English language

Exclusion Criteria:

1. Participant is unwilling or unable to give informed consent
2. Anyone without a good command of the English language
3. Anyone \<18 years of age and \>75 years of age
4. BMI greater than 45 kg/m²
5. A regular cannabis user i.e. weekly use
6. Have a terminal illness
7. A known sleep disorder that is not OSA
8. Regular use of the following medicines i.e. Weekly use: (Wakefulness promoting agents Modafinil, Amphetamine derivatives, Methylphenidate; Sedatives including benzodiazepines, Z-drugs (zopiclone, zolpidem \& zaleplon); Melatonin, including Circadin and melatonin analogues; Clonazepam and other drugs for nocturnal movement disorders).

Conditions3

Browse More Trials